dual IDO1/STAT3 inhibitors (Guangxi Normal University/Guilin Medical University/Southeast University)

N/A

Report date: 2025/03/19 11:37:31
NME

Base Information

Drug Namedual IDO1/STAT3 inhibitors (Guangxi Normal University/Guilin Medical University/Southeast University)
Drug Alias Namedual IDO checkpoint inhibitor/STAT3 inhibitor (Guangxi Normal University/Guilin Medical University/Southeast University)dual IDO-1 checkpoint inhibitor/STAT3 inhibitor (Guangxi Normal University/Guilin Medical University/Southeast University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitorsIndoleamine 2,3-dioxygenase inhibitors
TargetsSignal transducer and activator of transcription 3Indoleamine 2,3-dioxygenase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangxi Normal University
China Registration ClassN/A

Develop Information

Active CompaniesGuilin Medical UniversitySoutheast UniversityGuangxi Normal University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A